aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Core Viewpoint - The Law Offices of Howard G. Smith has announced a securities fraud class action lawsuit against aTyr Pharma Inc., inviting investors who suffered substantial losses to participate in the lawsuit [1][3]. Summary by Relevant Sections Lawsuit Details - The lawsuit alleges that between January 16, 2025, and September 12, 2025, aTyr Pharma Inc. failed to disclose critical information regarding its EFZO-FIT study, misleading investors about the drug Efzofitimod's potential to meet its primary endpoint [3]. - Specific allegations include the creation of adverse facts about the study design, misleading narratives about steroid removal for patients, and the failure of the Phase 3 EFZO-FIT study to meet its primary endpoint regarding the mean daily OCS dose at week 48 [3]. Participation Information - Investors interested in participating in the class action lawsuit must contact the Law Offices of Howard G. Smith before December 8, 2025, which is the lead plaintiff deadline [2][4]. - The law firm provides various contact methods, including email and telephone, for investors to discuss their legal rights [2][4].